MarketResearchReport2021

Antibiotic Resistance Market Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi, and parasites change when they are exposed to antimicrobial drugs. Antibiotic drugs include antibiotics, antifungals, antivirals, antimalarials, and anthelmintic. Antibiotic resistance market is expected to reach USD 17.12 billion by 2030 at CAGR of 5.34% during the forecast period of 2023 to 2030 The growth of global antibiotic resistance market is driven by various factors such as -      Rising antibiotic drug resistance infections, rise in the incidence of chronic and infectious disease, increase in clinical developments of antibiotic resistance, and rise in global initiatives to control drug-resistance Several market players currently dominate the global antibiotic resistance market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. Major Key Players: Some of the Antibiotic Resistance Mar

New-Born Screening Market Newborn screening is the practice of testing every newborn for some harmful or possibly fatal disorders that are not otherwise obvious at birth. New-born screening involves the use of various devices for the screening procedure. Diseases such as phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell disease, cystic fibrosis, tyrosinemia, and other such disorders can be screened using new-born screening devices. The rising prevalence of neonatal conditions and government support along with new-born screening programs have led to the growth of the new-born screening market in recent years. Additionally, increasing neonatal population and technological advancements are likely to contribute to the growth of the market over the assessment period. The new-born screening market is projected to reach USD 876.61 Million by 2030 at 8.20% CAGR during the forecast period 2022-2030 The key factors driving the market growth are increasing spending by g

Insulin Pumps Market The global market is anticipated to witness growth owing to the factors such as growing prevalence of diabetes as well as the increasing awareness about the disease . However, the market will face challenges and restraints due to expenses associated with insulin and the rise in insulin cost during the forecast period. The insulin Pumps Market is expected to reach USD 11.5 Billion by 2028, at CAGR of 15.5% asserts Market Research Future (MRFR). The growing development activities in the market is set to play a key role in determining the growth potential during forecast year. Analysts have also studied the market to understand potential threats and challenges the insulin pumps market companies could face. Although the market is poised to grow at a fast pace across type, accessories, end-users, and applications segments, factors such as the growing inclination towards naturopathy could slow down the insulin pumps market's growth worldwide. Major Key Pla

Ligation Devices Market Ligation devices are used during surgeries for closing incisions or to join separated organs/tissue parts. The Ligation Devices Market is expected to reach USD 586.12 million by 2030 at 5.20% CAGR during the forecast period 2022-2030. Favorable reimbursement policies, rising healthcare expenditure, an increasing number of surgeries, and growing research and development expenditures are the factors driving the market growth. According to the Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) was estimated to be the most common type of heart disease within the US and was projected to cause 370,000 per year. However, the high cost of surgery and related side effects are estimated to restraint the market growth. Major Key Players: Market Research Future (MRFR) recognizes the Ligation Devices Market Players are Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex

Viral Vector Manufacturing Market Viral vector manufacturing refers to the production of a carrier called a vector which is genetically engineered to deliver the gene because they can deliver the new gene by infecting the cell.  Considered as a drug substance, viral vectors are used in gene therapy and vaccinology (vaccines). In the case of cell therapies, the scrutiny for testing for adventitious agents is high. Viruses that are often used as vectors include retroviruses that integrate their genetic material including the new gene in the human cell, and adenoviruses, that introduce their DNA into the nucleus of the cell without letting the DNA to integrate into a chromosome. These viruses are modified so they can't cause disease when used in people. Gene therapy has seen various clinical advancement, and along with it, the viral vector manufacturing market is growing pervasively. Gene therapy is one of the most preferred treatment options for a number of chronic diseases. Ov

  Liquid Handling System Market Liquid handling system simply out is an effective laboratory instrument system that comprises of equipment and tools designed for mixing, combining liquid samples and sampling. It is widely used in laboratories as it helps in reducing the time needed to perform laboratory tasks along with increasing the accuracy and work efficiency. Liquid handling systems are available in various forms ranging from liquid handling workstations that is robotic assisted and integrated with the cloud-based software to simple volumetric pipettes that are used for transferring volumes of liquids that is desired in different life science experiments. It has wide application including protein crystallization, next-generation gene sequencing, microarray spotting, genomic extraction, medicine and chemical manufacturing, cell-based assays, serial dilution, biological preparation as well as handling. Liquid handling system market is expected to register a CAGR of 6.4% with US

Atrial Fibrillation Market Atrial fibrillation is a disorder of the pace or the rhythm of the heart. It is caused by unsystematic electrical activity in the atria of the heart, which causes rapid stimulus of the ventricles, leading to an irregular heartbeat. Numerous factors such as advancements in minimally invasive surgeries to treat atrial fibrillation, appropriate and timely intervention of the healthcare delivery systems, and increased incidence rates of the risk factors are expected to drive the growth of the market during the forecast period. Atrial fibrillation market is expected to reach USD 3.59 billion by 2030 at a CAGR 13.30% during the forecast period of 2023-2030 The global atrial fibrillation market is currently dominated by many market players. The key players in the market are engaged in new product launches and strategic collaborations to strengthen its market position. For instance, in January 2017, Abbott completed the acquisition of St. Jude Medical, Inc. St